{"chebi_id":"66919","chebi_name":"ruxolitinib","chebi_synonyms":["(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile","INCB018424"],"diffprof_id_observed":["MTBLS6890_0002_00000001"],"diffprof_id_var_observed":[],"inchikey":"HFNKQEVNSGCOJV-OAHLLOKOSA-N","inn_name":"ruxolitinib","iupac_name":"(3<i>R</i>)-3-cyclopentyl-3-[4-(7<em>H</em>-pyrrolo[2,3-<em>d</em>]pyrimidin-4-yl)-1<em>H</em>-pyrazol-1-yl]propanenitrile","num_study_observed":1,"reactome_ids":["R-HSA-1266695","R-HSA-1280215","R-HSA-1643685","R-HSA-168256","R-HSA-449147","R-HSA-451927","R-HSA-5663205","R-HSA-6785807","R-HSA-877300","R-HSA-8985947","R-HSA-9020558","R-HSA-909733","R-HSA-913531","R-HSA-9679191","R-HSA-9679506","R-HSA-9824446"],"reactome_names":["Interleukin-7 signaling","Cytokine Signaling in Immune system","Disease","Immune System","Signaling by Interleukins","Interleukin-2 family signaling","Infectious disease","Interleukin-4 and Interleukin-13 signaling","Interferon gamma signaling","Interleukin-9 signaling","Interleukin-2 signaling","Interferon alpha/beta signaling","Interferon Signaling","Potential therapeutics for SARS","SARS-CoV Infections","Viral Infection Pathways"],"study_id_observed":["MTBLS6890"],"study_id_var_observed":[],"synonym_name":"INCB018424"}